KR860000486B1 - 옥사졸리딘디온 유도체의 제조 방법 - Google Patents

옥사졸리딘디온 유도체의 제조 방법 Download PDF

Info

Publication number
KR860000486B1
KR860000486B1 KR8204569A KR820004569A KR860000486B1 KR 860000486 B1 KR860000486 B1 KR 860000486B1 KR 8204569 A KR8204569 A KR 8204569A KR 820004569 A KR820004569 A KR 820004569A KR 860000486 B1 KR860000486 B1 KR 860000486B1
Authority
KR
South Korea
Prior art keywords
spiro
group
hydrogen
oxindole
oxazolidinedione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR8204569A
Other languages
English (en)
Korean (ko)
Other versions
KR840002002A (ko
Inventor
제프리 허취슨 알란
Original Assignee
윌리암 데이비스 헌
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윌리암 데이비스 헌, 화이자 인코포레이티드 filed Critical 윌리암 데이비스 헌
Publication of KR840002002A publication Critical patent/KR840002002A/ko
Application granted granted Critical
Publication of KR860000486B1 publication Critical patent/KR860000486B1/ko
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR8204569A 1981-10-13 1982-10-11 옥사졸리딘디온 유도체의 제조 방법 Expired KR860000486B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31068281A 1981-10-13 1981-10-13
US310682 1981-10-13

Publications (2)

Publication Number Publication Date
KR840002002A KR840002002A (ko) 1984-06-11
KR860000486B1 true KR860000486B1 (ko) 1986-04-30

Family

ID=23203647

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8204569A Expired KR860000486B1 (ko) 1981-10-13 1982-10-11 옥사졸리딘디온 유도체의 제조 방법

Country Status (16)

Country Link
EP (1) EP0079675A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5877883A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR860000486B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR231839A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU531161B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1171860A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK449882A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES515751A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI823480L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR77019B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU185113B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL66954A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH18038A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL238595A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT75673B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU229382A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
WO1988009661A1 (en) * 1987-06-10 1988-12-15 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US5221686A (en) * 1992-08-04 1993-06-22 American Home Products Corporation Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
CN102336769A (zh) * 2011-07-06 2012-02-01 华东理工大学 一种简便的合成螺[氧化吲哚-3,5'-噁唑啉]杂环化合物的新方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones

Also Published As

Publication number Publication date
KR840002002A (ko) 1984-06-11
JPS5877883A (ja) 1983-05-11
PT75673A (en) 1982-11-01
ES8400116A1 (es) 1983-10-16
EP0079675A1 (en) 1983-05-25
AU8928882A (en) 1983-04-21
PH18038A (en) 1985-03-08
CA1171860A (en) 1984-07-31
GR77019B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-04
ES515751A0 (es) 1983-10-16
YU229382A (en) 1984-12-31
FI823480A7 (fi) 1983-04-14
AR231839A1 (es) 1985-03-29
FI823480A0 (fi) 1982-10-12
AU531161B2 (en) 1983-08-11
PT75673B (en) 1985-12-09
FI823480L (fi) 1983-04-14
DK449882A (da) 1983-04-14
IL66954A (en) 1985-02-28
JPS611073B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-01-13
IL66954A0 (en) 1983-02-23
PL238595A1 (en) 1983-09-12
HU185113B (en) 1984-12-28

Similar Documents

Publication Publication Date Title
JPS6323881A (ja) 1,2,3,3a,8,8a−ヘキサヒドロ−3a,8(および1,3a,8)−ジ(およびトリ)メチルピロロ〔2,3−b〕インド−ルおよびそれらの製造法
RU2042663C1 (ru) Производные бензола и их соли
HU184712B (en) Process for producing dextrorotating trans-2-substituted-5-phenyl-2,3,4,4a,5,9b,hexahydro-h-pyrido-bracket-4,3,b-bracket closedindol derivatives
US4145427A (en) N- 1-(3-Benzoyl-propyl)-4-piperidyl!-sulfonic acid amides and salts thereof
KR860000486B1 (ko) 옥사졸리딘디온 유도체의 제조 방법
US4587256A (en) Novel thiazolidine derivatives
JPH0825877B2 (ja) 眼科治療用組成物
US4169150A (en) Benzodiazepine derivatives and pharmaceutical compositions containing said derivatives
JPH07505120A (ja) チアフィゾベニンのカルバミン酸類縁化合物、医薬品用組成物、ならびにコリンエステラーゼ阻害方法
LU86421A1 (fr) Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention
EP0019440B1 (en) Benzimidazolone derivatives, process for their preparation and pharmaceutical compositions containing them
US4464380A (en) Imidazolidinedione derivatives
US4581366A (en) Aldose reductase inhibition by spiro indoline derivatives
KR940006635B1 (ko) 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법
CA1226866A (en) Hydantoin derivatives
JPS5839829B2 (ja) スルホニルニヨウソカゴウブツ ノ セイゾウホウホウ
US4539329A (en) 7'-Trifluoromethyl-spiro[imidazolidine-4,3'-indoline]-2,2',5-triones as aldose reductase inhibitors
FR2477153A1 (fr) Spiro dihydrobenzofuranne-piperidines et-pyrrolidines, leur procede de preparation et leur application pharmaceutique
AU595467B2 (en) Azolidinedione derivatives
US4533667A (en) Imidazolidinedione derivatives
JPH04330076A (ja) ヘキサヒドロピロロ〔2,3−b〕インドールカルバメート、−尿素、−アミドおよび関連化合物
US3961065A (en) Benzenesulfonylurea derivatives
JPS6112689A (ja) 環式アミド、その製法及び該化合物を含有する糖尿病及びガラクトース血症の合併症を治療又は予防するための製薬的組成物
CN101460474A (zh) 作为钾通道开放剂的3,4-二氨基-3-环丁烯-1,2-二酮衍生物
Szabó et al. Synthesis of quinazolino‐1, 3‐benzothiazine derivatives

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19890501

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19890501

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000